(Q58209790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Tong PC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ko GT

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Chan WB

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

So WY

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Lo MK

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Lee KF

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ozaki R

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Chow CC

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Cockram CS

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Chan JC

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

Diabetes, Obesity and Metabolism

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

342-347

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00514.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00514.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00514.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00514.X

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00514.X

Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00514.X

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00514.X

Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00514.X

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00514.X

10.1111/J.1463-1326.2005.00514.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634995%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference